June 05, 2019
The National Law Journal (NLJ) has recognized Silicon Valley partner Judith Hasko, Global Vice Chair of the Healthcare & Life Sciences Practice, in its inaugural Technology Law Trailblazers report, which features lawyers that are “agents of change… who have made significant marks on the practice, policy, and technological advancements in their sector.”
In her published profile, Hasko recounted how her education and private sector work experience involving “novel science to make the impossible possible” helped shape her career as a transactional attorney advising industry-leading life sciences companies. As examples of Hasko’s groundbreaking work, the NLJ cited her advice to Daiichi Sankyo in its recent multi-billion dollar collaboration with AstraZeneca to develop and commercialize cancer therapies, and her representation of Juno Therapeutics in a landmark agreement with Celgene Corporation to develop and commercialize novel immunotherapies to treat cancer and autoimmune diseases.
“Every larger deal I do is groundbreaking, in that the technology our clients are developing is unique and the risks and benefits are very different,” Hasko said.